Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 27:11:1182463.
doi: 10.3389/fbioe.2023.1182463. eCollection 2023.

Editorial: Advanced technologies in bioengineering to fight antimicrobial resistance

R Vázquez  1 , V Rivero-Buceta  2 , R Del Campo  3   4 , I Poblete-Castro  5 , C Herencias  3   4
Affiliations
Editorial

Editorial: Advanced technologies in bioengineering to fight antimicrobial resistance

R Vázquez et al. Front Bioeng Biotechnol. .
No abstract available

Keywords: antimicrobial resistance; gene editing systems; microbial growth; natural toxin production; phage therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Advanced technologies in bioengineering to fight antimicrobial resistance

References

    1. Bikard D., Euler C. W., Jiang W., Nussenzweig P. M., Goldberg G. W., Duportet X., et al. (2014). Exploiting CRISPR-cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32, 1146–1150. 10.1038/nbt.3043 - DOI - PMC - PubMed
    1. Fernández-Olmos A., García-Castillo M., María Alba J., Morosini M. I., Lamas A., Romero B., et al. (2013). Population structure and antimicrobial susceptibility of both nonpersistent and persistent Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. J. Clin. Microbiol. 51, 2761–2765. 10.1128/JCM.00802-13 - DOI - PMC - PubMed
    1. Herencias C., Rodríguez-Beltrán J., León-Sampedro R., Alonso-del Valle A., Palkovičová J., Cantón R., et al. (2021). Collateral sensitivity associated with antibiotic resistance plasmids. eLife 10, e65130. 10.7554/eLife.65130 - DOI - PMC - PubMed
    1. Lin D. M., Koskella B., Lin H. C. (2017). Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 8, 162. 10.4292/wjgpt.v8.i3.162 - DOI - PMC - PubMed
    1. Meirelles L. A., 1 I. D., Perry E. K., Bergkessel M., Newmanid D. K. (2021). Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics. 10.1371/journal.pbio.3001093 - DOI - PMC - PubMed

Publication types

LinkOut - more resources